本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

阿諾醫藥

2.00
+0.17009.29%
成交量:302.00
成交額:612.23
市值:7,380.05萬
市盈率:-0.86
高:2.00
開:2.00
低:2.00
收:1.83
資料載入中...
2025/05/01

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/02/14

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/01/27

SEC問詢函

Form CORRESP - Correspondence
2025/01/02

SEC問詢函

Form CORRESP - Correspondence
2024/05/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/19

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/04

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/31

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/27

SEC問詢函

Form CORRESP - Correspondence
2023/09/27

SEC問詢函

Form CORRESP - Correspondence
2023/09/27

SEC問詢函

Form CORRESP - Correspondence
2023/09/27

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/09/12

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/09/12

SEC問詢函

Form CORRESP - Correspondence
2023/08/14

SEC問詢函

Form CORRESP - Correspondence
2023/08/14

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]